| Year |
Citation |
Score |
| 2021 |
Lee SC, Ma JSY, Kim MS, Laborda E, Choi SH, Hampton EN, Yun H, Nunez V, Muldong MT, Wu CN, Ma W, Kulidjian AA, Kane CJ, Klyushnichenko V, Woods AK, et al. A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Science Advances. 7. PMID 34380625 DOI: 10.1126/sciadv.abi8193 |
0.651 |
|
| 2018 |
Cejalvo T, Perisé-Barrios AJ, Portillo ID, Laborda E, Rodriguez-Milla MA, Cubillo I, Vázquez F, Sardón D, Ramirez M, Alemany R, Castillo ND, Garcia-Castro J. Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy. Cancer Research. PMID 29991502 DOI: 10.1158/0008-5472.Can-17-3754 |
0.449 |
|
| 2017 |
Laborda E, Mazagova M, Shao S, Wang X, Quirino H, Woods AK, Hampton EN, Rodgers DT, Kim CH, Schultz PG, Young TS. Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 18. PMID 29077054 DOI: 10.3390/Ijms18112259 |
0.418 |
|
| 2017 |
Laborda E, Hampton EN, Lee SC, Woods AK, Young TS. A Novel Switchable CAR-T Platform for Acute Lymphoblastic Leukemia Treatment Blood. 130: 3890-3890. DOI: 10.1182/Blood.V130.Suppl_1.3890.3890 |
0.732 |
|
| 2014 |
Puig-Saus C, Rojas LA, Laborda E, Figueras A, Alba R, Fillat C, Alemany R. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Therapy. 21: 767-74. PMID 24942629 DOI: 10.1038/Gt.2014.52 |
0.379 |
|
| 2014 |
Laborda E, Puig-Saus C, Rodriguez-García A, Moreno R, Cascalló M, Pastor J, Alemany R. A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 986-98. PMID 24448161 DOI: 10.1038/Mt.2014.7 |
0.373 |
|
| Show low-probability matches. |